UCI Health Want one thing new to enliven your holiday menu?
- But UC Davis Health infectious illness consultants explain why they’re not a replacement for the COVID-19 vaccine.
- Around 49 patients have been treated with LentiGlobin until now, according to the gene remedy’s developer, pharmaceutical firm Bluebird Bio.
- When the pandemic hit, they quickly adapted to make sure their sufferers might continue to access the care they needed.
- Omicron is the most recent coronavirus variant that has emerged, but specialists say low vaccination rates may result in further mutations.
The lab-repaired stem cells are then implanted and start producing wholesome …
